Wenlin Li

Pfizer (United States)

Papers

2

Total Citations

139

H-Index

2

About

Wenlin Li is a pioneering bioanalytical chemist whose work has significantly advanced the high-throughput quantification of drugs and neurotransmitters in biological systems. Li’s primary research focuses on developing semi-automated sample preparation techniques and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for pharmacokinetic and neurochemical studies. Their most cited work, "Semi-automated 96-well liquid–liquid extraction for quantitation of drugs in biological fluids" (2000, 76 citations), introduced a robust, efficient protocol that streamlined drug analysis in complex matrices, reducing manual labor and improving reproducibility. Complementing this, Li’s validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC-MS/MS (2000, 63 citations) provided a critical tool for Parkinson’s disease research, enabling precise monitoring of these key biomarkers. These contributions have been widely adopted in pharmaceutical and academic labs, with combined citations exceeding 139, underscoring their lasting impact on bioanalytical methodology. Li’s work exemplifies the integration of automation and mass spectrometry to solve real-world analytical challenges, making them a key figure in advancing drug development and neuroscience.

Research Focus

Key Achievements

2
H-Index
2
Papers
139
Total Citations
70
Avg Citations/Paper
🏆 Most Cited Paper
Semi-automated 96-well liquid–liquid extraction for quantitation of drugs in biological fluids
76 citations · 2000
📈 Most Prolific Year: 2000 (2 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago